Bracco Imaging company information, Employees & Contact Information

Bracco Elevates Next Generation of Radiologists, Announces Recipients of the 2022 "Leaders on the Horizon" Residency Program PR Newswire

Bracco and the Society for Advanced Body Imaging (SABI) Announce Partnership in Launch of the New SABI Bracco Mentorship Program PR Newswire

Bracco Diagnostics Inc. Unveils Contrast Media and Device Offerings That Can Help Build Value and Drive Revenue in Clinical Practice at the 2019 Radiological Society of North America (RSNA) Annual Meeting PR Newswire

Bracco Announces U.S. FDA Approval of 20-Vial Configuration of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use PR Newswire

Bracco Diagnostics Inc. Announces New Partnership to Increase Access to Cardiac PET Imaging PR Newswire

Bracco Diagnostics Inc. Receives First U.S. FDA Approval For Barium-Based Product Used For Contrast Radiography PR Newswire

Bracco Diagnostics Inc. Receives Innovative Technology Designation from Vizient for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension for Contrast Echocardiography PR Newswire

Voluntary dismissal of Norris case PR Newswire

FDA Grants Import Discretion of Bracco's Iodinated Contrast Medium Iomeron® (iomeprol injection) to Address Supply Shortages PR Newswire

Bracco Diagnostics Inc. Introduces New CardioGen-82® (Rubidium Rb 82 Generator) Infusion System PR Newswire

Bracco Diagnostics Inc. Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography PR Newswire

Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL in magnetic resonance imaging (MRI) of the central nervous system (CNS) in pediatric patients young PR Newswire

FDA Approves Bracco Diagnostics Inc.'s ProHance® (Gadoteridol) Injection, 279.3 mg/mL, for Pediatric Patients Younger than Two Years PR Newswire

Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound PR Newswire

BRACCO IMAGING S.p.A. ANNOUNCES A NEW AGREEMENT WITH SONOTHERA™ TO EXPLORE THE EMERGING FIELD OF ULTRASOUND-GUIDED NONVIRAL GENE THERAPY PR Newswire

Bracco Launches Global "BRACCO CARES" Initiative to Support Healthcare Professionals Through Trying Times PR Newswire

Bracco Diagnostics Inc.'s LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use, receives U.S. Food and Drug Administration approval for use in ultrasonography of the urinary tract in pedia PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® THIN LIQUID (barium sulfate) for oral suspension PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL™ V (Barium Sulfate) Oral Suspension PR Newswire

First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® PUDDING (barium sulfate) oral paste for Fluoroscopy PR Newswire

Bracco Diagnostics Inc. AuntMinnie

Bracco Diagnostics Inc. announces the launch of the PROTOCO2L TOUCH® Colon Insufflator for use in CT Colonography procedures PR Newswire

Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package b PR Newswire

Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR® NECTAR (barium sulfate) Oral Suspension PR Newswire

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol PR Newswire

Importance of Myocardial Perfusion Positron Emission Tomography Recognized in New Joint Position Statement by the American Society of Nuclear Cardiology and the Society of Nuclear Medicine and Molecular Imaging PR Newswire

Artificial intelligence software confirms the results of a large scale comparison of ProHance® (Gadoteridol) Injection, 279.3 mg/mL and Gadavist® (gadobutrol) Injection in MRI of the brain (the TRUTH study) PR Newswire

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies PR Newswire

Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery PR Newswire

The United States Pharmacopeia (USP) Defines the Imaging Bulk Package (IBP) as the Only Suitable Container of Contrast Material for Multi-Dose, Multi-Patient Use Directly in Radiology Rooms PR Newswire

The Centers For Medicare & Medicaid Services (CMS) Approved Coverage And Coding For Abdominal Ultrasound With Contrast Under The Hospital Outpatient Prospective Payment System (HOPPS) Effective October 1, 2016 PR Newswire

New study of ultrasound enhancing agents in echocardiography reaffirms safety profile of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use PR Newswire

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer Imaging Technology News

Bracco Imaging and Subtle Medical Announce CE Mark of AiMIFY™ Software for Enhanced MRI in Europe PR Newswire

Blue Earth Therapeutics Advances Clinical Development of Lutetium (177Lu) rhPSMA-10.1 Injection with Promising Phase 1 Data PR Newswire

Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals Business Wire

Blue Earth Diagnostics, a Bracco Company, Lauds CMS Proposal to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals Business Wire

Varibar Thin Liquid Gets FDA Approval for Modified Barium Swallow Studies Medical Professionals Reference

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial PR Newswire

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency PR Newswire

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth Business Wire

Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer PR Newswire

Blue Earth Therapeutics Reports Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial PR Newswire

Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer Business Wire

Bracco Diagnostics Inc. Introduces CitraClear™, a Refreshing Pre-Procedure Hydration Solution, to the Healthcare Community PR Newswire

Bracco Imaging SpA and BDP International Achieve Pharma Transportation ‘First’ GlobeNewswire

Bracco Diagnostics Inc. Introduces Innovative "Mini" Packaging for VARIBAR® (barium sulfate), Catering to Diverse Customer Needs PR Newswire

Lumason Approved for Pediatric Patients With Suboptimal Echocardiograms Medical Professionals Reference

Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent Imaging Technology News

First U.S. Lumason Echocardiography Imaging Procedure Performed Diagnostic and Interventional Cardiology

Philochem and Blue Earth Diagnostics Announce First Three GlobeNewswire

First U.S. Lumason Echocardiography Imaging Procedure Performed Imaging Technology News

Bracco Acquires Contrast Injector Maker Swiss Medical Care Imaging Technology News

Bracco Acquires Contrast Injector Maker Swiss Medical Care Diagnostic and Interventional Cardiology

Bracco's CT Exprès™ 3D Contrast Media Delivery System is the First and Only Syringe-Less Computed Tomography (CT) Power Injector Available in the U.S. PR Newswire

Varibar Pudding Approved for Use in Oropharyngeal Evaluation Medical Professionals Reference

Blue Earth Therapeutics Presents Modelling Data Supporting Early Dose Intensification of Lutetium (177Lu) rhPSMA-10.1 Injection in mCRPC PR Newswire

Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for Pediatric MRI Imaging Technology News

Customized Solutions Meet the Demands of an Evolving Radiology Market Diagnostic and Interventional Cardiology

Bracco Creates Multi-Dose Compliant Contrast Medium for Point-of-Care Use in the CT Suite Diagnostic and Interventional Cardiology

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer Business Wire

Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Business Wire

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA Business Wire

MultiHance launched in Russia healthcare-in-europe.com

Blue Earth Therapeutics Announces Clinical Research Collaboration with UCL to Develop Innovative Alpha-labelled Radioligand Therapy (RLT) for Prostate Cancer Business Wire

Latest Trends in Contrast Media Injectors Diagnostic and Interventional Cardiology

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial mx.advfn.com

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer to Lead Company’s Next Phase of Business Growth NTB Kommunikasjon

Recent Trends and Developments in Contrast Media Imaging Technology News

Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension Imaging Technology News

Customized Solutions Meet the Demands of an Evolving Radiology Market Imaging Technology News